Identification of Spen as a Crucial Factor for Xist Function through Forward Genetic Screening in Haploid Embryonic Stem Cells  by Monfort, Asun et al.
ReportIdentification of Spen as a Crucial Factor for Xist
Function through Forward Genetic Screening in
Haploid Embryonic Stem CellsGraphical AbstractHighlightsd A haploid embryonic stem cell screen identifies factors
required for Xist function
d The RNA-binding protein Spen is required for gene
repression by Xist
d Recruitment of Polycomb group proteins by Xist is affected in
the absence of Spen
d Spen binds Xist A-repeat RNA but cannot discriminate
functional from mutant motifsMonfort et al., 2015, Cell Reports 12, 554–561
July 28, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.06.067Authors
Asun Monfort, Giulio Di Minin, Andreas





In mammals, one of the two X
chromosomes is inactivated in female
cells by the noncoding Xist RNA for
dosage compensation. Monfort et al. use
haploid embryonic stem cells to identify
silencing factors and demonstrate that
the RNA-binding protein SPEN is required
for gene repression by Xist.
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In mammals, the noncoding Xist RNA triggers tran-
scriptional silencing of one of the two X chromo-
somes in female cells. Here, we report a genetic
screen for silencing factors in X chromosome inacti-
vation using haploid mouse embryonic stem cells
(ESCs) that carry an engineered selectable reporter
system. This system was able to identify several
candidate factors that are genetically required for
chromosomal repression by Xist. Among the list of
candidates, we identify the RNA-binding protein
Spen, the homolog of split ends. Independent valida-
tion through gene deletion in ESCs confirms that
Spen is required for gene repression by Xist. How-
ever, Spen is not required for Xist RNA localization
and the recruitment of chromatin modifications, in-
cluding Polycomb protein Ezh2. The identification
of Spen opens avenues for further investigation into
the gene-silencing pathway of Xist and shows the
usefulness of haploid ESCs for genetic screening of
epigenetic pathways.
INTRODUCTION
In mammals, one of the two X chromosomes in female cells
is inactivated for dosage compensation between the sexes
(Lyon, 1961); thereby, random chance determines which of
the two chromosomes remains transcriptionally active and
which is inactivated. X chromosome inactivation has become
a paradigm for chromosome-wide gene repression in mam-
mals. The human XIST (Brown et al., 1991a, 1991b) and mouse
Xist (Borsani et al., 1991; Brockdorff et al., 1991) genes encode
long noncoding RNAs that accumulate over the X chromosome
from whence they are transcribed and initiate chromatin mod-
ifications and gene silencing. Xist is required for X chromosome
inactivation and female mouse development (Marahrens et al.,
1997; Penny et al., 1996). Conversely, transgenic expression of554 Cell Reports 12, 554–561, July 28, 2015 ª2015 The AuthorsXist is sufficient for initiation of repression in early embryonic
cells (Jiang et al., 2013; Lee et al., 1996; Wutz and Jaenisch,
2000).
Studies of Xist have identified a number of factors that
contribute to the structure and repression of the inactive X
chromosome (Xi). The histone variant macroH2A (Costanzi and
Pehrson, 1998) and the nuclear scaffold protein SAF-A/hnRNPU
(Helbig and Fackelmayer, 2003) are enriched on the Xi. Poly-
comb/Trithorax group proteins, including Eed (Wang et al.,
2001) and Ash2L (Pullirsch et al., 2010), have been implicated
in X inactivation. In addition, multiple functions have been pro-
posed for YY1 in X inactivation, including Xist RNA localization
(Jeon and Lee, 2011) and Xist transcription (Makhlouf et al.,
2014). Whereas Xist is not essential for maintenance of gene
repression in somatic cells (Brown and Willard, 1994), loss of
Xist in mice has recently been shown to lead to Xi reactivation
in blood cells and leukemia (Yildirim et al., 2013). A genetic
screen for epigenetic modifiers in mice has identified the
SmcHD1 gene, which is required for maintaining DNA methyl-
ation and repression of Xi-linked gene promoters (Blewitt et al.,
2008). We have previously identified SatB1 as a factor that is
required for the initiation of gene repression in a mouse T-cell
lymphomamodel (Agrelo et al., 2009). However,SatB1 is unlikely
a key factor for gene silencing in the mouse embryo, as a muta-
tion is compatible with female development (Nechanitzky et al.,
2012). Themechanism that Xist uses for initiation of gene repres-
sion remains elusive.
Mouse embryonic stem cells (ESCs) provide a tractable cul-
ture system for recapitulating the different steps involved in X
inactivation. To advance our understanding of the silencing
pathway of Xist, we considered forward genetic screening using
recently developed mouse haploid embryonic stem cells (ESCs)
(Elling et al., 2011; Leeb and Wutz, 2011). Mutations in a haploid
genome are hemizygous and efficiently reveal cellular pheno-
types. Screens in haploid cells have been successful in uncover-
ing toxin- and pathogen-related host factors (Jae et al., 2014).
The maintenance of pluripotent characteristics of haploid ESCs
makes them useful for addressing developmental questions
(Leeb et al., 2014) and facilitates the genetic exploration of initi-




Figure 1. Characterization of Xist-Inducible
Mouse Haploid ESCs
(A) Structure of the Xist inducible system.
(B) Chromosome spread of haploid HATX ESCs.
(C) Xist induction (+ dox) leads to loss of cells
compared to growth in absence of doxycycline (no
dox).
(D) Xist RNA FISH in HATX3 ESCs grown with and
without doxycycline.
(E) Immunofluorescence image showing focal
Ezh2 and H3K27me3 staining in HATX3 ESCs after
Xist induction.
(F) qRT-PCR analysis showing induction of Xist
and repression of X-linked genes in HATX3 ESCs
after doxycycline addition. The autosomal b-actin
gene is shown as a control. NT, nontreated.
(G) Flow cytometry profile of HATX3 ESCs before
(red) and after (green) infection with gene trap
viruses. DNA content (left) and GFP fluorescence
(right) of a gene trap encoded reporter are shown.
A mixed haploid/diploid DNA content profile is
shown for reference in gray.RESULTS
A Genetic Screen for Silencing Factors
Wederived haploid ESC lines from XistTX/TXR26nlsrtTA/nlsrtTA mice
that carry an inducible promoter inserted within the Xist locus
and a tetracycline-regulated transactivator targeted to the
ROSA 26 locus on chromosome 6 (Savarese et al., 2006) (Fig-
ure 1A). We obtained 11 haploid ESC lines (HATX-1 to HATX-
11) from a total of 170 activated oocytes (Figure 1B). Addition
of doxycycline to HATX cultures induced Xist expression from
the single X chromosome and caused cell loss (Figures 1C and
1D). After Xist induction, we observed focal recruitment of the
Polycomb protein Ezh2 and the associated histone modificationCell Reports 12, 554–H3K27me3 (Figure 1E). qRT-PCR anal-
ysis further showed the repression of
X-linked genes, but not of an autosomal
control gene, after Xist induction in
HATX ESCs (Figure 1F). These observa-
tions are consistent with earlier findings
that Xist expression initiates X inactivation
in ESCs (Wutz and Jaenisch, 2000; Wutz
et al., 2002). In haploid cells, loss of
gene expression from the single-X chro-
mosome is not compatible with cell
survival. The Xist-induced lethality then
provides an efficient selection strategy
for recovering mutations abrogating the
silencing pathway of Xist and, therefore,
preventing Xist-dependent cell death.
For generating a genome-wide set of
mutations, we adopted a viral gene trap
mutagenesis strategy that has been pre-
viously devised for screening in haploid
human tumor cells (Carette et al., 2009).
We infected 80 million haploid HATX
ESCs, which were sorted for a haploid
genome content one passage earlier, with a high-titer gene
trap vector retrovirus preparation. We confirmed efficient infec-
tion by analyzing the fluorescence of a promoter-less EGFP re-
porter that is encoded by the gene trap virus (Jae et al., 2014)
(Figure 1G). The cell pools were subsequently divided into two
samples that were either subjected to selection by inducing
Xist expression or cultured without doxycycline for obtaining
control samples. DNA from both control and selected samples
was prepared and used for identification of viral insertion sites
through next-generation sequencing (NGS) (Carette et al.,
2009). We calculated the number of independent insertions for
each gene in selected and control data sets and ranked candi-





Figure 2. Mutation of Spen in ESCs
(A) Schematic representation of viral gene trap
insertions in Xist and Spen locus (not to scale,
gene size is indicated). Chr, chromosome.
(B) Schematic representation of the Spen gene
locus showing the location of CRISPR/Cas9 guide
RNAs (gRNAs) used for engineering a deletion and
genotyping PCR primers.
(C) Genomic PCR confirming the absence of wild-
type Spen fragment in Spen mutant ESCs.
(D) Quantitative expression analysis of Spen using
primer sets spanning exons as indicated. DSpen
ESCs lack transcript from the deleted region. Error
bars represent SD (n = 3).
(E) Cell survival of control HATX3 ESCs and
derived DSpen ESCs clone 2 (top; n = 2) and clone
3 (bottom; n = 3) after Xist induction (+ dox). Sur-
vival was calculated relative to uninduced cells.
Error bars represent SD.
See also Figure S1.in selected samples over controls. As anticipated, Xistwas found
on top of the list of candidates (Tables S1 and S2). Insertions
were preferentially observed within the 50-most region of Xist
and in an orientation that aligns the poly-adenylation sequences
of the gene trapwith the transcription unit consistent with the po-
tential termination of Xist transcription (Figure 2A). The ROSA26
locus from which the tetracycline responsive transactivator nls-
rtTA is expressed was also among the selected candidates. A
large number of insertions further mapped within the nls-rtTA
cDNA (Figure S1), demonstrating that our screen robustly recov-
ered factors that were anticipated from the technical setup of the
screen.556 Cell Reports 12, 554–561, July 28, 2015 ª2015 The AuthorsThe list of candidates included the
chromatin assembly factors Hira and
Ubn2, the kinase Cdk8, a subunit of the
mediator complex Med25, the RNA-bind-
ing protein Spen, and one hypothetical
gene Gm3139 (Figure S1; Tables S1–
S3). For all candidates except Gm3139,
we could observe a strong bias for gene
trap insertions in the orientation of the
transcription of the gene in selected but
not control data sets, which suggests
that potential loss-of-function mutations
had been enriched. These observations
suggest that the selected candidates are
involved in Xist-mediated gene silencing.
However, different mechanisms can be
considered: (1) direct interaction with
Xist, (2) affecting Xist expression, and (3)
indirect effects from regulating gene
expression and signal transduction in
pluripotent cells. Indirect effects likely
explain the recovery of general regulators
of gene expression such as Hira and
Med25. In contrast, Spen (also called
Mint and Sharp) possesses RNA-binding
domains and has been previously impli-
cated in gene repression (Arieti et al., 2014; Kuroda et al.,
2003; Shi et al., 2001), which suggests it as a potential
silencing factor of Xist. Therefore, we selected Spen for further
characterization.
Spen Is Required for Xist-Mediated Gene Repression
in ESCs
Spen was enriched in all seven selected samples over controls,
indicating that mutations were recovered with high reproduc-
ibility. Distribution and orientation of gene trap virus insertions
were, furthermore, consistent with a high likelihood of inducing
loss-of-functionmutations (Figure 2A). To independently validate
Spen as a silencing factor, we used CRISPR/Cas9 nucleases for
engineering a deletionwithin the gene (Figure 2B).Wedeleted the
Spen exons encoding the RNA-binding domains and nuclear
localization signals in HATX ESCs and clone 36 ESCs, which
carry an inducible Xist transgene on chromosome 11 (Wutz and
Jaenisch, 2000). CRISPR/Cas9 nucleases have previously been
shown to be very efficient and can yield homozygous mutations
(Doudna andCharpentier, 2014). Our strategy involved the simul-
taneous use of two guide RNAs for deleting a large fragment of
the transcription unit of Spen. Using this strategy, we were suc-
cessful in obtaining two independent ESC clones with Spen de-
letions inHATX3ESCsandoneclonewith ahomozygousdeletion
ofSpen in clone 36 ESCs.We confirmed the deletion by genomic
PCR and Southern blot analysis (Figure 2C; Figures S2A and
S2B). qRT-PCR showed an absence of transcript over the
deleted region, but the remaining exons appeared to give rise
to a transcript of considerably higher abundance than wild-type
Spenmessage (Figure 2D).
Next, we investigated whether mutation of Spen abrogates the
ability of Xist to induce X inactivation. For this, we measured cell
survival after Xist induction. Whereas induction of Xist caused
cell loss in parental HATX3 ESCs, cells with a deletion of Spen
appeared unaffected (Figure 2E). To further confirm that Xist
was induced and repression of X-linked genes was abrogated,
we performed qRT-PCR analysis. Xist induction was observed
24 and 48 hr after doxycycline addition in Spenmutant and con-
trol cells (Figure 3A). Repression of X-linked genes was observed
in HATX3 control cells but not in cells carrying a Spen deletion.
Autosomal control genes remained unaffected by Xist in both
Spen mutant and wild-type cells (Figure 3B). Taken together,
these observations showed that a mutation in Spen abrogated
the ability of Xist for initiating gene repression. We further
analyzed the effect of the Spen deletion in clone 36 ESCs, in
which Xist induction represses a puromycin-resistance gene
that was co-integrated with the Xist transgene into chromosome
11 and the imprintedMeg1 gene. Xist induction caused efficient
repression of the puromycinmarker after 48 hr in control cells but
less efficient repression in cells lacking Spen (Figure S2C).
Consistent with this observation, Spen mutant cells showed an
increased survival in the presence of puromycin and less efficient
silencing of Meg1 when Xist was induced (Figures S2D–S2F),
indicating that loss of Spen also led to a reduced efficiency of
Xist-mediated repression in 36 ESCs. Taken together, our results
demonstrate that Spen is required for gene repression by Xist in
ESCs.
To further explore whether the RNA-binding domains of Spen
could bind to Xist, we focused on the A-repeat motif that has
been shown previously to be required for initiation of silencing
(Wutz et al., 2002). The interaction of three Spen RRM domains
with the noncoding steroid receptor RNA activator (SRA) has
been recently investigated in detail (Arieti et al., 2014). We per-
formed electrophoretic mobility shift experiments with purified
recombinant Spen RRM domains, using the H12-H13 substruc-
ture of SRA and a dimer of Xist A-repeat motifs (XCR), which
has a similar length as that of SRA, as radiolabeled probe.
We found that Spen RRMs can bind XCR (Figure 3C) and
that XCR also competes for SRA binding (Figures S2G and
S2H). Experiments using in-vitro, T7-transcribed, as well asfully synthetic RNAs indicate that XCR can bind to Spen
RRMs similarly to SRA, whereas tRNA does not compete for
binding. We also observed that two mutant XCR RNAs (XS1
and XNX) that are not active in initiating gene silencing (Wutz
et al., 2002), nonetheless, can compete for binding to Spen
RRMs (Figure 3D). These results show that Spen can bind to
Xist A-repeat sequences in vitro. However, under our condi-
tions, the binding specificity cannot fully explain the silencing
function of Xist A-repeat, potentially reflecting technical limita-
tions of our assay or indicating that other factors cooperate
with Spen in binding to Xist A-repeat in vivo.
Mutation of Spen Does Not Affect Xist Localization but
Reduces Recruitment of Polycomb Proteins
To further explore whether loss of Spen affected Xist-mediated
chromatin modifications, we performed Xist RNA fluorescence
in situ hybridization (FISH) and immunofluorescence staining.
Xist clusters in control and Spen mutant cells appeared with
similar efficiency (Figures S2F, S3A, and S3B), suggesting that
Xist localization was not affected by the deletion of Spen. The
Polycomb proteins Ezh2 and Ring1b were also recruited by
Xist, and focal enrichment of H3K27me3 could be observed in
the absence of Spen (Figures 4A and 4C; Figures S3 and S4).
Similarly, Xist clusters appeared in a volume that was character-
ized by low signals of acetylated histone H4 and RNA polymer-
ase II, consistent with the presence of a repressive compartment
(Figures 4E and 4F). However, Ezh2 and H3K27me3 foci were
less prominent in Spen mutant cells compared to control cells.
Combined immunofluorescence staining and RNA FISH showed
that the efficiency of Ring1b and Ezh2 recruitment to the Xist
cluster was reduced in Spen mutant cells (Figures 4B, 4D, and
S4). Taken together, these data demonstrate that loss of Spen
resulted in a decreased efficiency of recruitment of chromatin
modifications by Xist in ESCs. These results are consistent
with previous observations that a mutant Xist RNA lacking
A repeat can localize and recruit chromatin modifications but
does not initiate gene repression (Wutz et al., 2002). The
A-repeat mutant Xist RNA also displays a strong deficit in Poly-
comb recruitment in ESCs, but recruitment increases upon entry
of ESCs into differentiation (Kohlmaier et al., 2004). However, we
did not see an increase in efficiency of recruitment of Ring1b and
Ezh2 in Spen mutant cells upon entry in differentiation (Figures
4B and 4D).
DISCUSSION
The mechanism of X chromosome inactivation has been subject
to many studies, but the genetic requirements for initiation of
gene repression have remained elusive. To advance the genetic
basis of the initiation of X inactivation in a developmentally rele-
vant cell system, our study combines haploid ESCs that carry a
developmentally validated selection system with saturation
mutagenesis as a statistically robust method for the identifica-
tion of candidate genes.
Our data demonstrate that Spen is required for Xist-mediated
silencing in ESCs. Spen possesses four RNA-recognition motif
(RRM) domains and is a predominantly nuclear protein. Mutation




Figure 3. Spen Is Required for Xist Function in ESCs and Binds Xist A-Repeat Sequences In Vitro
(A andB)qRT-PCRanalysis of theX-linkedgenes (A) and theautosomal control genes (B) as indicated inHATXandSpenmutantESCs.Error bars representSD (n=3).
The locations of the genes tested on the X chromosome (chr) is shown at the left. q represents the region of the chromosome. +dox, Xist induction; NT, nontreated.
(C) Electrophoretic mobility shift analysis of Spen RRM domains using a 32P-labeled synthetic XCR RNA probe and cold XCR, SRA, and tRNA competitors as
indicated. Asterisk and black triangle indicate position of the RNA-protein complex and free probe, respectively.
(D) Competition with cold XS1 and XNX competitors as in (C).
See also Figure S2.




Figure 4. Mutation of Spen Reduces Re-
cruitment of Polycomb Proteins
(A, C, E, and F) Combined Xist RNA FISH and Ezh2
(A), Ring1b (C), acetylated histone H4 (E), and RNA
polymerase II (F) immunofluorescence analysis of
Spen mutant and control ESCs after 24 hr of in-
duction with doxycycline. Scale bar, 5 mm.
(B and D) Quantification of focal recruitment of
Ezh2 (B) and Ring1b (D) by Xist expression in
2i-cultured (2i) and 24-hr-differentiated (retinoic
acid; RA) ESCs (n = 100). cl 2 and cl 3 represent
clones 2 and 3, respectively.
See also Figures S3 and S4.which might be partly attributable to a repressive function in the
Notch signaling pathway (Yabe et al., 2007).Spen is further impli-
cated in nuclear hormone receptor signaling and interacts with
the regulatory noncoding SRA RNA through its RRM domains
(Arieti et al., 2014; Shi et al., 2001). Its repressor function and
the binding ofSpenRRMdomains to XistA-repeat are consistent
with the expected properties of silencing factors, but we cannot
exclude additional factors that regulate the interaction with Xist.
Two recent studies have also identified Spen as an interactor of
Xist, using biochemical strategies (Chu et al., 2015; McHugh
et al., 2015). Both studies implicate Spen in X inactivation, with
slightly different mechanisms. The finding that the Spen proteinCell Reports 12, 554–is detected more abundantly when the
Xist A-repeat is present (Chu et al.,
2015) is consistent with our observation
that Spen RRMs have binding activity
for XistA-repeat coremotifs in vitro. How-
ever, our data also suggest that this
RNA-binding specificity does not fully
explain the silencing function of Xist
A-repeat. Notably, depletion of Spen by
RNAi has been reported to abrogate
Polycomb recruitment by Xist by prevent-
ing deacetylation of histones (McHugh
et al., 2015). We do observe a reduction,
but not a complete block, of Polycomb
recruitment in the absence of Spen.
To reconcile the different findings, we
consider technical differences between
RNAi-mediated depletion and our engi-
neered genetic deletion of Spen exons
encoding its RNA-binding domains.
Whereas our mutation abrogates gene
repression by Xist to a large extent, we
observe a moderate and transient reduc-
tion of genes close to Xist, including Ftx,
Rnf12, and Pgk1 in HATX DSpen ESCs
(Figure 3A). We find that Xist can recruit
Polycomb proteins and form a repressive
compartment characterized by low RNA
polymerase II and acetylated histone H4
in DSpen ESCs, suggesting that multiple
interactions between Spen and Xistmight
exist. The genetic implication of Spen will
facilitate further advances on the gene-silencing pathways that
operate during X inactivation.
EXPERIMENTAL PROCEDURES
Cell Culture and Generation of Transgenic Cell Lines
Derivation of haploid ESCs from XistTX/TX R26nlsrtTA/nlsrtTA mice was performed
as previously published (Leeb and Wutz, 2011). For introducing a deletion into
the Spen gene locus (Figure 2A) using the CRISPR/Cas system, previously
published guide RNA sequences (Koike-Yusa et al., 2014) against Spen exons
(gRNA3 Fw: GGGGTGTCTCCTGCGCATT; gRNA5 Fw: CGGACAAGACA
TTACGATC) were inserted into the pX330-U6-Chimeric_BB-CBh-hSpCas9
vector (Addgene, #42230). Briefly, the vectors were lipofected into HATX3561, July 28, 2015 ª2015 The Authors 559
cells, together with a GFP reporter vector in a 5:1 ratio. 48 hr later, cells were
sorted for green fluorescence and replated to a very low density for isolating
individual clones. Spen deletions were identified by PCR on genomic DNA,
using the primers 50-GTCGTCCCTGTAGATATCCCTGTG-30 and 50-CAGA
AAGAGGCGAGGCGTAAAG-30 (Figure S2A). Fgfr2 primers were used as
controls (50-ATTTCTTGGCACCAGACAGG-30 and 50-TGCCAACTCCAGAG
GACTTT-30 ).
Screening in Haploid ESCs
107 sorted haploid ESCs were grown in 3 3 145 cm2 dishes for 3 days and
harvested. Haploid cells were infected with gene trap virus as previously
described (Jae et al., 2014) and plated on 10 3 145 cm2 dishes. After
3 days, each dish was split into two 145-cm2 dishes, one used as control
and one for selection. For selection, Xist expression was induced by addition
of 1 mg/ml doxycycline. Every 3 days, half of the selected cells were passaged
and half of the cell pool was used for DNA extraction up to passage 5. Library
preparation and computational analysis of sequencing datasets are detailed
in the Supplemental Experimental Procedures. The sequencing datasets
are deposited in the NCBI Short-Read Archive (http://www.ncbi.nlm.nih.gov/
sra) and can be accessed using accession numbers SRX1060416 and
SRX1060407.
Immunofluorescence and RNA Analysis
Immunofluorescence staining was performed as previously described
(Pullirsch et al., 2010). For further details, see Supplemental Experimental
Procedures. For gene expression analysis, RNA was isolated using
the QiAshredder (QIAGEN, #79656), purified using the RNeasy Mini Kit
(QIAGEN, #74104) and reverse transcribed into cDNA. Real-time PCR
was performed using SYBR Green and a LightCycler 480 System (Roche).
Eif4a2 was used for normalization. For details, see Supplemental Experi-
mental Procedures.
Electrophoretic Mobility Shift Assay
Binding studies were performed using purified recombinant Spen RRM
domain protein and either chemically synthesized or T7 in-vitro-transcribed
RNA as previously described (Arieti et al., 2014). For experimental details,
see Supplemental Experimental Procedures.
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The sequencing datasets are deposited in the NCBI Short-Read Archive
(http://www.ncbi.nlm.nih.gov/sra) and can be accessed using accession
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four figures, and three tables and can be found with this article online at
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